Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q2 2025 · 148 positions · Total reported value $1.76B · Top-10 concentration 22.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Invenomic Capital Management LP disclosed 148 equity positions with a combined reported value of $1.76B. The filing implies a diversified portfolio: its ten largest positions account for 22.8% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q2 2025 were GPN ($49.07M), XRAY ($46.46M), VTRS ($41.46M). By sector, the heaviest allocations are Consumer Discretionary 26.1%, Technology 20.0%. Versus the prior quarter, allocation shifted toward Financials (+5.0pp), Health Care (+3.7pp) and away from Industrials (-1.2pp), Communication Services (-3.9pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 57% of names.

The largest new positions opened in Q2 2025 were RNG ($40.47M), OMC ($15.48M), COP ($14.81M).

Of the 35 positions fully exited versus the prior quarter, the largest were DNB ($33.59M), SLB ($23.67M), MUR ($19.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • RNG RINGCENTRAL INC · $40.47M
  • OMC OMNICOM GROUP INC · $15.48M
  • COP CONOCOPHILLIPS · $14.81M
  • ABM ABM INDS INC · $12.65M
  • GNRC GENERAC HLDGS INC · $10.65M
  • PHIN PHINIA INC · $10.20M
  • RYN RAYONIER INC · $9.90M
  • ZBH ZIMMER BIOMET HOLDINGS INC · $8.13M

Fully Exited (vs previous quarter)

  • DNB DUN & BRADSTREET HLDGS INC · prev qtr: $33.59M
  • SLB SLB LIMITED · prev qtr: $23.67M
  • MUR MURPHY OIL CORP · prev qtr: $19.43M
  • EZPW EZCORP INC · prev qtr: $18.10M
  • ZM ZOOM COMMUNICATIONS INC · prev qtr: $16.58M
  • ES EVERSOURCE ENERGY · prev qtr: $16.56M
  • HII HUNTINGTON INGALLS INDS INC · prev qtr: $15.65M
  • ABNB AIRBNB INC · prev qtr: $14.19M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 20.0%
Health Care 15.4%
Industrials 12.7%
Materials 5.9%
Financials 5.0%
Energy 2.9%
Other 12.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 613.02K $49.07M 2.79%
2.79%
Add
2 2.93M $46.46M 2.64%
2.64%
Add
3 4.64M $41.46M 2.35%
2.35%
Reduce
4 2.03M $41.33M 2.35%
2.35%
Reduce
5 1.43M $40.47M 2.30%
2.30%
New
6 9.39M $40.36M 2.29%
2.29%
Add
7 686.92K $36.31M 2.06%
2.06%
Add
8 1.19M $35.94M 2.04%
2.04%
Reduce
9 2.24M $35.37M 2.01%
2.01%
Reduce
10 427.92K $34.13M 1.94%
1.94%
Reduce
11 284.38K $33.66M 1.91%
1.91%
Reduce
12 1.37M $31.03M 1.76%
1.76%
Add
13 158.05K $30.66M 1.74%
1.74%
Add
14 2.67M $30.63M 1.74%
1.74%
Add
15 644.56K $29.82M 1.69%
1.69%
Add
16 630.60K $29.32M 1.66%
1.66%
Add
17 414.45K $28.43M 1.61%
1.61%
Add
18 645.64K $28.12M 1.60%
1.60%
Reduce
19 350.46K $27.15M 1.54%
1.54%
Add
20 357.62K $26.58M 1.51%
1.51%
Reduce
21 1.47M $26.25M 1.49%
1.49%
Reduce
22 563.19K $25.48M 1.45%
1.45%
Add
23 1.93M $22.09M 1.25%
1.25%
Reduce
24 1.88M $21.87M 1.24%
1.24%
Add
25 2.41M $20.98M 1.19%
1.19%
Add
26 1.07M $20.97M 1.19%
1.19%
Reduce
27 4.23M $20.92M 1.19%
1.19%
Add
28 3.62M $20.80M 1.18%
1.18%
Add
29 213.66K $20.69M 1.18%
1.18%
Reduce
30 182.97K $20.16M 1.15%
1.15%
Add
31 127.28K $20.06M 1.14%
1.14%
Add
32 580.96K $18.22M 1.03%
1.03%
Add
33 1.22M $17.70M 1.00%
1.00%
Add
34 1.24M $17.34M 0.98%
0.98%
Add
35 1.07M $17.04M 0.97%
0.97%
Add
36 485.35K $15.74M 0.89%
0.89%
Add
37 1.69M $15.60M 0.89%
0.89%
Reduce
38 215.17K $15.48M 0.88%
0.88%
New
39 657.52K $15.21M 0.86%
0.86%
Add
40 869.23K $15.18M 0.86%
0.86%
Add
41 790.40K $14.99M 0.85%
0.85%
Reduce
42 165.05K $14.81M 0.84%
0.84%
New
43 1.63M $14.51M 0.82%
0.82%
Reduce
44 110.36K $14.48M 0.82%
0.82%
Reduce
45 2.12M $14.46M 0.82%
0.82%
Reduce
46 8.29M $14.27M 0.81%
0.81%
Add
47 1.58M $13.13M 0.74%
0.74%
Reduce
48 295.10K $13.08M 0.74%
0.74%
Add
49 267.85K $12.65M 0.72%
0.72%
New
50 1.45M $12.60M 0.71%
0.71%
Add

FAQ

What did Invenomic Capital Management LP buy in 2025-Q2?

In its 2025-Q2 13F filing, Invenomic Capital Management LP reported 148 equity positions worth $1.76B in aggregate; its largest disclosed positions were GPN ($49.07M), XRAY ($46.46M), VTRS ($41.46M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $1.76B of long equity holdings across 148 positions as of 2025-Q2. Top-10 holdings account for 22.8% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →